Search Results for: Cognition Therapeutics Receives Fast Track
Articles
October 24, 2017
Cognition Therapeutics Receives Fast Track Designation for First-in-Class Alzheimer’s Candidate October 24, 2017
Cognition Therapeutics, Inc., a clinical-stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease...
February 6, 2023
Endogena Therapeutics Receives Fast Track Designation for EA-2353 for the Treatment of Retinitis Pigmentosa February 6, 2023
Endogena Therapeutics Inc. recently announced the US FDA has designated the investigation of EA-2353 for the treatment of retinitis pigmentosa...
November 10, 2022
Akari Therapeutics Granted FDA Rare Pediatric Disease Designation of Nomacopan for the Treatment of Pediatric HSCT-TMA November 10, 2022
Akari Therapeutics, Plc recently announced the US FDA has granted the Rare Pediatric Disease Designation to nomacopan for the treatment...
May 24, 2022
Synlogic Receives Positive Opinion on Orphan Designation From the EMA for SYNB1618 for the Treatment of Phenylketonuria May 24, 2022
Synlogic, Inc. recently announced the European Medicines Agency (EMA) issued a positive opinion on the company’s application for orphan designation...
February 4, 2021
Theratechnologies’ Lead Peptide Drug Conjugate TH1902 Receives FDA Fast-Track Designation February 4, 2021
Theratechnologies Inc. recently announced the US FDA has granted fast-track designation to TH1902 as a single agent for the treatment...
